Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (67)

2024

  1. Capacidad del biomarcador suPAR para estratificar el pronóstico en pacientes atendidos en servicios de urgencias hospitalarios

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 1, pp. 17-24

  2. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

    Vaccines, Vol. 12, Núm. 8

  3. Report of the International Council for Standardization in Haematology working group for standardization of reticulocyte parameters

    International Journal of Laboratory Hematology, Vol. 46, Núm. 2, pp. 266-274

  4. Usefulness of extended inflammatory parameters related to neutrophil activation reported by Sysmex XN-1000 hematology analyzer for predicting complicated acute appendicitis. Comparison with canonical inflammatory laboratory tests

    Cirugia Espanola, Vol. 102, Núm. 6, pp. 300-306

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Additions to the paper 'The Journey of Laboratory Medicine' from a broader perspective

    Journal of Clinical Pathology

  3. Diagnostic performance of machine learning models using cell population data for the detection of sepsis: a comparative study

    Clinical Chemistry and Laboratory Medicine, Vol. 61, Núm. 2, pp. 356-365

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. GATEKEEPER's Strategy for the Multinational Large-Scale Piloting of an eHealth Platform: Tutorial on How to Identify Relevant Settings and Use Cases

    Journal of medical Internet research, Vol. 25, pp. e42187

  6. Gender differences in the management of acute psychiatric episodes in the emergency department: a cross-sectional analysis of the 2017–2019 triennium

    Archives of Women's Mental Health, Vol. 26, Núm. 6, pp. 777-783

  7. Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections

    Journal of Laboratory and Precision Medicine, Vol. 8

  8. Prediction of significant coronary artery disease in acute chest pain without infarction in emergency department: MAPAC Cardio-PreTest model

    European Journal of Emergency Medicine, Vol. 30, Núm. 1, pp. 40-46

  9. Predictores de evolución no adversa en pacientes con COVID-19: escala CoNAE (COVID-19 non-adverse evolution)

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 35, Núm. 5, pp. 335-344

  10. Recent advances in laboratory hematology reflected by a decade of CCLM publications

    Clinical Chemistry and Laboratory Medicine, Vol. 61, Núm. 5, pp. 829-840

  11. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

    The Lancet Regional Health - Europe, Vol. 28

  12. Violence in first-episode psychosis: Evidence from an early intervention in psychosis programme

    BJPsych Open, Vol. 9, Núm. 5

2022

  1. Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)

    Scientific Reports

  2. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  3. Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department

    Clinical Chemistry and Laboratory Medicine

  4. Effectiveness of the vagino-rectal exudate self-sampling for prenatal screening of Streptococcus agalactiae infection. GALL study

    Atencion Primaria, Vol. 54, Núm. 6